In this report, we demonstrate that the novel small molecule compound NVP-AUY922 potently inhibits HSP90 in vitro, has good pharmaceutical and pharmacological properties, and exhibits potent antitumor activity at tolerated doses in an ER- and ERBB2-positive human breast cancer model. This evidence concerns the gene HSP90AA1 and breast cancer.